During the past decade, Genentech Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genentech Inc" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Genentech Inc" are "HIV Infections" (2 trials), "Colorectal Cancer" (1 trials), "Dwarfism, Pituitary" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Genentech Inc" in a lesser frequency.

Most popular intervention types in "Genentech Inc" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "CD4 Antigens" (2 trials) and "pirfenidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genentech Inc" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Genentech Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Genentech Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Genentech Inc, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".